Enliven Therapeutics, Inc. Common Stock (ELVN) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ELVN. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 201 institutions reported holding ELVN, with 79.9 million shares worth $4.0 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 10,025,017 | $509M | INCREASED |
| Orbimed Advisors | 6,776,632 | $344M | DECREASED |
| Polar Capital Holdings | 6,430,636 | $326M | INCREASED |
| BlackRock | 4,359,704 | $221M | INCREASED |
| Vestal Point Capital | 4,000,000 | $203M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Enliven Therapeutics, Inc. Common Stock on SentiSense.